Product Information

APREPITANT 125 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $111.2434 per EA under NDC 13668059386. Its NADAC has been published 101 times since Dec 18, 2024.

FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

APREPITANT 125 MG CAPSULE

APREPITANT
$111.2434per EA

Strength

125 mg/1

NDC

13668059386

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA211835

FDA Approved

10/21/2020

TE Code

AB

On Market Since

10/21/2020

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price Statistics

The NADAC for APREPITANT 125 MG CAPSULE has been published 101 times since Dec 18, 2024, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.

Current price$111.2434 per EA
All-time high$199.2198 (Sep 10, 2025)
All-time low$111.2434 (Nov 18, 2026)
52-week high$178.3444
52-week low$111.2434
Median price$169.1683
Average price$154.5385
Largest weekly change-11.9% (Jan 21, 2026)
Weeks tracked101
Tracking sinceDec 18, 2024

Price History

1W

-1.0%

1M

-2.5%

3M

-3.4%

6M

-4.8%

1Y

-37.6%

3Y

N/A

5Y

N/A

All

-38.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the APREPITANT market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of APREPITANT 125 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 125 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $111.2434 per EA (NDC 13668059386), effective Nov 18, 2026.

How has the price of APREPITANT 125 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for APREPITANT 125 MG CAPSULE has declined 38.9%. It has been tracked across 101 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for APREPITANT 125 MG CAPSULE?

Since Dec 18, 2024, the NADAC for APREPITANT 125 MG CAPSULE has ranged from a low of $111.2434 (Nov 18, 2026) to a high of $199.2198 (Sep 10, 2025), with a median of $169.1683 per EA.

Are there cheaper alternatives to APREPITANT 125 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of APREPITANT 125 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures APREPITANT 125 MG CAPSULE?

APREPITANT 125 MG CAPSULE (NDC 13668059386) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.